Tilray Brands, Inc.
NASDAQ:TLRY · NASDAQ Global Select
-$0.04 today
Vol 3.38M · Avg 4.73M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+31.02%
Period High
$21.00
Period Low
$3.61
Latest
$4.73
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Neogen Corporation
NASDAQ:NEOG
$1.98B
Dynavax Technologies Corporation
DVAX
$1.82B
Immunome, Inc.
NASDAQ:IMNM
$1.74B
Intellia Therapeutics, Inc.
NASDAQ:NTLA
$1.71B
Harrow Health, Inc.
NASDAQ:HROW
$1.56B
Maze Therapeutics, Inc.
NASDAQ:MAZE
$1.40B
Phibro Animal Health Corporation
NASDAQ:PAHC
$1.28B
Alvotech
NASDAQ:ALVO
$1.22B
Evotec SE
NASDAQ:EVO
$921.71M
Amphastar Pharmaceuticals, Inc.
NASDAQ:AMPH
$842.62M
What is the latest TLRY filing?
The latest filing shown is 8-K dated Jun 9, 2026.
How many recent filings does TLRY have?
Intrinsic Alpha currently shows 20 recent filings for TLRY.
Explore More
Continue the stock analysis
Jump to another research area for this company.